Skip to main content

Advertisement

Log in

Emphysematous Pyelonephritis: a Review of a Rare Condition

  • Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Emphysematous pyelonephritis (EPN) is a rare condition which is potentially life threatening. It is characterised by gas formation within the collecting system, renal parenchyma and/or perirenal tissues. Diabetes is the single most common risk factor for the development of EPN. Other risk factors include urinary tract obstruction and immunocompromise. Escherichia Coli is the most common pathogen. EPN is characterised by fever, loin pain and systemic upset. Gold standard diagnosis and classification of EPN is made with contrast CT. Classification can be used as a prognostic indicator for mortality and to guide management. EPN may be managed conservatively or surgically. Patients managed conservatively are resuscitated and administered with intravenous antibiotics. Intravenous fluid, glucose control for diabetics and acid base balance are vital components for primary management. For those in whom conservative management is unsuccessful, a parenchymal drain may be considered to drain gas or a collection of pus. Patients with hydronephrosis will benefit from a nephrostomy or JJ stent insertion. Patients who have failed minimally invasive surgical intervention or who have a number of risk factors predisposing them to EPN should undergo either immediate or delayed nephrectomy. With treatment for EPN now moving away from nephrectomy towards less invasive interventions, mortality rates for EPN are improving but remaining high.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, et al. Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect. 2001;34(2):125–30.

    CAS  PubMed  Google Scholar 

  2. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797–805.

    Article  CAS  PubMed  Google Scholar 

  3. Wan YL, LeeTY BMJ, Tsai CC. Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology. 1996;198:433–8.

    Article  CAS  PubMed  Google Scholar 

  4. Somani BK, Nabi G, Thorpe P, et al. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol. 2008;179:1844–9.

    Article  PubMed  Google Scholar 

  5. Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009;6:272–9.

    Article  PubMed  Google Scholar 

  6. Behera V, Vasantha Kumar RS, Mendonca S, Prabhat P, Naithani N, Nair V. Emphysematous infections of the kidney and urinary tract: a single-center experience. Saudi J Kidney Dis Transpl. 2014;25(4):823–9.

    Article  PubMed  Google Scholar 

  7. Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis. 2014;14:418. A valuable article as it ascertains predictors of failure with conservative management, thereby helping practitioners to identify the cohort of patients who would benefit from early percutaneous drainage.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int. 2011;107(9):1474–8.

    Article  PubMed  Google Scholar 

  9. Arsene C, Saste A, Arul S, Mestrovich J, Kammo R, Elbashir M, et al. A case series of emphysematous pyelonephritis. Case Rep Med. 2014;2014:587926.

    PubMed Central  PubMed  Google Scholar 

  10. Kim MJ, Park JS, Lim HJ, Jung J, Shin DG, Lee KD, et al. Emphysematous pyelonephritis caused by citrobacter freundii in a patient with type 2 diabetes and neurogenic bladder. Infect Chemother. 2013;45(3):331–4.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Bhat RA, Bashir G, Wani M, Lone S. Emphysematous pyelonephritis caused by Candida parapsilosis: an unknown etiological agent. N Am J Med Sci. 2012;4(8):364–6.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Narlawar RS, Raut AA, Nagar A, Hira P, Hanchate V, Asrani A. Imaging features and guided drainage in emphysematous pyelonephritis: a study of 11 cases. Clin Radiol. 2004;59:192–7.

    Article  CAS  PubMed  Google Scholar 

  13. Das CJ, Ahmad Z, Sharma S, Gupta AK. Multimodality imaging of renal inflammatory lesions. World J Radiol. 2014;6(11):865–73.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol. 1984;131(2):203–8.

    CAS  PubMed  Google Scholar 

  15. Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in emphysematous pyelonephritis. J Urol. 1998;159(2):369–73.

    Article  CAS  PubMed  Google Scholar 

  16. Falagas ME, Alexiou VG, Giannopoulou KP, Seimpos II. Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol. 2007;178(3 pt 1):880–5.

    Article  PubMed  Google Scholar 

  17. Aswathaman K, Gopalakrishnan G, Gnanaraj L, Chacko NK, Kekre NS, Devasia A. Emphysematous pyelonephritis: outcome of conservative management. Urology. 2008;71(6):1007–9.

    Article  PubMed  Google Scholar 

  18. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and shock. N Engl J Med. 2001;345(19):1367–77.

    Article  Google Scholar 

  19. Mallet M, Knockaert DC, Oyen RH, Van Poppel HP. Emphysematous pyelonephritis: no longer a surgical disease? Eur J Emerg Med. 2002;9(3):266–9.

    Article  CAS  PubMed  Google Scholar 

  20. Nanki T, Ageishi Y, Iwama T, Murase H, Uchikawa T. Emphysematous pyelonephritis successfully treated with nephrectomy and granulocyte colony-stimulating factor. Intern Med. 1994;33(4):234–6.

    Article  CAS  PubMed  Google Scholar 

  21. Cheng YT, Wang HP, Hsieh HH. Emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and nephrostomy. Clin Transplant. 2001;15(5):374–7.

    Article  Google Scholar 

  22. Dellinger RP, Levy MM, Rhodes A, Annanne D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. Emphysematous Pyelonephritis often presents with sepsis. Early and appropriate management of sepsis is vital if mortality is to be avoided. Since the introduction of the surviving sepsis campaign, we have seen a 25 % improvement in mortality outcomes in sepsis.

    Article  PubMed  Google Scholar 

  23. Sharma PK, Sharma R, Vijay MK, Tiwari P, Goel A, Kundu AK. Emphysematous Pyelonephritis: our experience with conservative management in 14 cases. Urol Ann. 2013;5(3):157–62.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Laway BA, Bhat MA, Bashir MI, Ganie MA, Mir SA, Daga RA. Conservative management of emphysematous pyelonephritis. Indian J Endocrinol Metab. 2012;16(2):303–5.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Bhat RA, Khan I, Khan I, Palla N, Mir T. Emphysematous Pyelonephritis: outcome with conservative management. Indian J Nephrol. 2013;23(6):444–7. This paper identified risk factors that can be used to identify patients with a poorer prognosis and uses to this identify patients in whom conservative management should not be attempted.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Pontin AR, Barnes RD. Current management of emphysematous pyelonephritis. Nat Rev Urol. 2009;6(5):272–9.

    Article  PubMed  Google Scholar 

  27. Chen MT, Huang CN, Chou YH, Huang CH, Chiang CP, Liu GC. Percutaneous drainage in treatment of emphysematous pyelonephritis: 10-year experience. J Urol. 1997;157(5):1569–73.

    Article  CAS  PubMed  Google Scholar 

  28. Matsuura H, Kanai M, Tochigi H. A case of emphysematous pyelonephritis successfully treated with multiple CT guided percutaneous drainage procedures. Hinyokika Kiyo. 2013;59(8):527–30.

    PubMed  Google Scholar 

  29. Akpek S, Turgut T, Ozdemir H, Ilgit ET, Işik S. Emphysematous pyelonephritis: fatal outcome during percutaneous drainage. Eur J Radiol. 1998;26(3):287–9.

    Article  CAS  PubMed  Google Scholar 

  30. Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986–9.

    Article  PubMed  Google Scholar 

  31. Dhabalia JV, Nelivigi GG, Kumar V, Gokhale A, Punia MS, Pujari N. Emphysematous pyelonephritis: tertiary care centre experience in management and review of the literature. Urol Int. 2010;85(3):304–8.

    Article  PubMed  Google Scholar 

  32. Pontin AR, Barnes RD, Joffe J, Kahn D. Emphysematous pyelonephritis in diabetic patients. Br J Urol. 1995;75:71–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare that they have no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. M. Emara.

Additional information

This article is part of the Topical Collection on Inflammatory/Infectious Bladder Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahesan, T., Reddy, U.D., Chetwood, A. et al. Emphysematous Pyelonephritis: a Review of a Rare Condition. Curr Bladder Dysfunct Rep 10, 207–211 (2015). https://doi.org/10.1007/s11884-015-0303-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-015-0303-x

Keywords

Navigation